# Phase 1 disease trials recruiting: 204 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 204 trials in phase 1 for disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 disease trials: 204 rows for $10.20, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 9 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 204
- Recruiting or not yet: 204
- Read on: November 19, 2026

## Trials

The 25 newest of 204, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07940881 | A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, First in Human, Metastatic Solid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940881) |
| November 6, 2026 | NCT07923383 | An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates | Sanofi | Phase 1 | Not yet recruiting | Ulcerative Colitis, Crohn's Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923383) |
| November 5, 2026 | NCT07919210 | A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy... | ModernaTX, Inc. | Phase 1 | Not yet recruiting | Marburg Virus Disease (MVD) | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919210) |
| November 4, 2026 | NCT07915297 | Safety and Biodistribution of \[68Ga\]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC) | Luminance Biosciences Inc | Phase 1 | Not yet recruiting | Metastatic Breast Cancer | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915297) |
| November 3, 2026 | NCT07914387 | Stanford University Neurofiber Study | Stanford University | Phase 1 | Not yet recruiting | PARKINSON DISEASE (Disorder) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914387) |
| November 3, 2026 | NCT07913672 | A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD) | Memorial Sloan Kettering Cancer Center | Phase 1 | Recruiting | Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD) | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913672) |
| October 30, 2026 | NCT07906665 | A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS) | Sachi Bioworks Inc. | Phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis (ALS) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906665) |
| October 28, 2026 | NCT07901088 | A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions | AJU Pharm Co., Ltd. | Phase 1 | Not yet recruiting | Peripheral Arterial Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901088) |
| October 28, 2026 | NCT07900945 | Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants | Keymed Biosciences Co.Ltd | Phase 1 | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900945) |
| October 27, 2026 | NCT07897708 | A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older... | Pfizer | Phase 1 | Not yet recruiting | Alzheimer Disease | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897708) |
| October 26, 2026 | NCT07896187 | A Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS | Nuwacell Biotechnologies Co., Ltd. | Phase 1 | Not yet recruiting | PARKINSON DISEASE (Disorder), Cell Therapy, Human Induced Pluripotent Stem Cells, Deep Brain Stimulation, Phase 1... | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896187) |
| October 22, 2026 | NCT07889349 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 1 | Not yet recruiting | Alzheimer's Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889349) |
| October 21, 2026 | NCT07885605 | Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease | Ethyreal Bio, Inc. | Phase 1 | Recruiting | Thyroid Eye Disease (TED), Graves' Disease, Eye Diseases, Hereditary, Eye Diseases, Exophthalmos, Orbital Diseases... | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885605) |
| October 19, 2026 | NCT07880379 | MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and \[¹⁸F\]MK-0947 in... | XingImaging, LLC | Phase 1 | Recruiting | Parkinsons Disease (PD), Healthy Elderly Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880379) |
| October 14, 2026 | NCT07873229 | DDI Study of ECC0509 With Metformin, Midazolam, and Caffeine | Eccogene | Phase 1 | Not yet recruiting | Steatohepatitis, Nonalcoholic, Osteo Arthritis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873229) |
| October 6, 2026 | NCT07861152 | Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD) | Regeneron Pharmaceuticals | Phase 1 | Not yet recruiting | Graves' Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861152) |
| September 28, 2026 | NCT07843459 | A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) | Eli Lilly and Company | Phase 1 | Recruiting | Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid, Plasma | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843459) |
| September 24, 2026 | NCT07840027 | Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease | Tridem Bioscience FlexCo | Phase 1 | Recruiting | Parkinson Disease (PD), Idiopathic Parkinson's Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840027) |
| September 24, 2026 | NCT07838649 | Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity | Washington University School of Medicine | Phase 1 | Not yet recruiting | Lymphoma Cancer, Breast Cancer, Cancer of the Breast, Non-Hodgkin Lymphoma, Hodgkin Lymphoma | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838649) |
| September 23, 2026 | NCT07836452 | A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants | City Therapeutics | Phase 1 | Recruiting | Stargardt Disease 1, STGD1, Healthy Volunteers | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836452) |
| September 17, 2026 | NCT07826676 | Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease | Pontifícia Universidade Católica do Paraná | Phase 1 | Not yet recruiting | Graft vs Host Disease, Mesenchymal Stem Cell Transplantation | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07826676) |
| September 16, 2026 | NCT07822087 | A Phase 1 Study of ATORM-C in Patients With Crohn's Disease | ORGANOIDSCIENCES LTD. | Phase 1 | Recruiting | Crohn's Diseases, Crohn's Disease | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822087) |
| September 3, 2026 | NCT07801989 | Alaska Alliance for Community Engagement Phase II: Partnership for Action Toward Health | University of Alaska Fairbanks | Phase 1 | Not yet recruiting | Chronic Disease, Mental Health, Caridovascular Disease, Stress, Adolescent Health | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801989) |
| September 2, 2026 | NCT07799571 | Buprenorphine for the Management of Pain in Children With Sickle Cell Disease | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis, Sickle Cell Anemia Crisis, Sickle Cell Anemia in... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799571) |
| August 31, 2026 | NCT07795307 | Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease | Brigham and Women's Hospital | Phase 1 | Not yet recruiting | Alzheimer's Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795307) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 8 |
| Columbia University | 5 |
| Baylor College of Medicine | 4 |
| [Alnylam Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/alnylam-pharmaceuticals) | 3 |
| City of Hope Medical Center | 3 |
| University of Wisconsin, Madison | 3 |
| Nuwacell Biotechnologies Co., Ltd. | 2 |
| Brigham and Women's Hospital | 2 |
| [Keymed Biosciences Co.Ltd](https://specstream.ai/data/clinical-trials/company/keymed-biosciences-co-ltd) | 2 |
| Ruijin Hospital | 2 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| iCamuno Biotherapeutics Ltd. | 2 |
| University of Alabama at Birmingham | 2 |
| Eccogene | 2 |
| Denali Therapeutics Inc. | 2 |
| Washington University School of Medicine | 2 |
| National Cancer Institute (NCI) | 2 |
| University of California, San Diego | 2 |
| Xuanwu Hospital, Beijing | 2 |
| Tridem Bioscience FlexCo | 2 |
| University of California, San Francisco | 2 |
| National Institute of Mental Health (NIMH) | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| Amyloid Solution Inc | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 109 |
| China | 41 |
| Australia | 19 |
| United Kingdom | 13 |
| Canada | 10 |
| Japan | 10 |
| Netherlands | 8 |
| South Korea | 6 |
| Taiwan | 5 |
| Germany | 4 |
| France | 3 |
| New Zealand | 3 |
| Spain | 2 |
| Austria | 2 |
| Brazil | 1 |
| Greece | 1 |
| India | 1 |
| Switzerland | 1 |
| Russia | 1 |
| Norway | 1 |
| Iran | 1 |
| Malaysia | 1 |
| Singapore | 1 |
| Israel | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Surgery practices in the United States](https://specstream.ai/data/businesses/surgery-practices/united-states)
- [Peruvian restaurants in the United States](https://specstream.ai/data/businesses/peruvian-restaurants/united-states)
- [Jewelry manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-manufacturers/united-states)
- [Farming services in the United States](https://specstream.ai/data/businesses/farming-services/united-states)
- [Chemical plants in the United States](https://specstream.ai/data/businesses/chemical-plants/united-states)
- [Anesthesiology practices in the United States](https://specstream.ai/data/businesses/anesthesiology-practices/united-states)
